Comparing Envoy Medical (NASDAQ:COCH) and Bionik Laboratories (OTCMKTS:BNKL)

Envoy Medical (NASDAQ:COCH) and Bionik Laboratories (OTCMKTS:BNKL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.

Institutional & Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. 0.7% of Envoy Medical shares are held by company insiders. Comparatively, 34.7% of Bionik Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Envoy Medical and Bionik Laboratories’ revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$320,000.00	199.06	-$29.91 million	N/A	N/A
Bionik Laboratories	$1.80 million	0.00	-$4.95 million	N/A	N/A

Bionik Laboratories has higher revenue and earnings than Envoy Medical.

Analyst Ratings

This is a breakdown of recent recommendations for Envoy Medical and Bionik Laboratories, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	3	0	3.00
Bionik Laboratories	0	0	0	0	N/A

Envoy Medical presently has a consensus price target of $7.38, suggesting a potential upside of 126.92%.

Profitability

This table compares Envoy Medical and Bionik Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-4,564.57%	N/A	-125.15%
Bionik Laboratories	N/A	N/A	N/A

Volatility and Risk

Envoy Medical has a beta of 2.33, meaning that its share price is 133% more volatile than the S&P 500. Comparatively, Bionik Laboratories has a beta of -1.1, meaning that its share price is 210% less volatile than the S&P 500.

Summary

Bionik Laboratories beats Envoy Medical on 5 of the 8 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Bionik Laboratories

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.